Correlation Between Oric Pharmaceuticals and Lyell Immunopharma

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and Lyell Immunopharma, you can compare the effects of market volatilities on Oric Pharmaceuticals and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Lyell Immunopharma.

Diversification Opportunities for Oric Pharmaceuticals and Lyell Immunopharma

-0.25

Correlation Coefficient

Oric Pharmaceuticals  Lyell Immunopharma

Very good diversification

The 3 months correlation between Oric and Lyell is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Lyell Immunopharma go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and Lyell Immunopharma

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the Lyell Immunopharma. In addition to that, Oric Pharmaceuticals is 1.1 times more volatile than Lyell Immunopharma. It trades about -0.06 of its total potential returns per unit of risk. Lyell Immunopharma is currently generating about -0.02 per unit of volatility. If you would invest  65.00  in Lyell Immunopharma on December 27, 2024 and sell it today you would lose (9.00) from holding Lyell Immunopharma or give up 13.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Oric Pharmaceuticals  vs.  Lyell Immunopharma

Oric Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Lyell Immunopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lyell Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Oric Pharmaceuticals and Lyell Immunopharma

The main advantage of trading using opposite Oric Pharmaceuticals and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.

The idea behind Oric Pharmaceuticals and Lyell Immunopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.